Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GZR18 in Chinese Obese/Overweight Patients
NCT06256536Phase 2Completed
- Sponsor
- Gan & Lee Pharmaceuticals
- Start
- Jul 2022
- Primary completion
- Oct 2023
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bofanglutide in obesity, Overweight, sponsored by Gan & Lee Pharmaceuticals. Started Jul 2022; status: completed.
02
Drugs
bofanglutide
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on NCT06256536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06256536.